Leo Ma
Associate Scientific Director - Chemistry, Manufacturing & Controls Analytical Team Lead Bristol Myers Squibb
Seminars
Wednesday 5th November 2025
Exploring In-Process Control Strategy for Drug-Linker Synthesis & Conjugation Process Development
2:30 pm
- Leveraging multiple analytical tools to understand and define optimal conjugation process
- Using analytical tools to understand and define the end of reduction, conjugation, and TFF purification process operations
- Utilizing purging data of small molecule impurities during development to justify the release/stability specification of final ADC drug substance
